Transcatheter Edge-to-Edge Repair Replaces Open Surgical Annuloplasty
Interventional cardiologists increasingly specify transcatheter edge-to-edge repair devices over open surgical annuloplasty for higher-risk patients, since catheter-based correction lets frail elderly patients avoid the recovery burden and mortality risk of open-heart surgery entirely across most anatomies. That clinical preference is pulling procurement toward transcatheter platform makers even where device cost runs considerably higher than comparable surgical rings, because heart teams increasingly recommend the catheter-based option once patients are deemed higher surgical risk. Abbott and Edwards Lifesciences have both expanded transcatheter repair product lines specifically to capture programmes replacing conventional surgical annuloplasty.
Market Impact: Expands diagnosed pool 12-18% yearl








